A Multidisciplinary Housestaff-Led Initiative to Safely Reduce Daily Laboratory Testing
Wade T. Iams(Vanderbilt University Medical Center), Sunil Kripalani(Vanderbilt University Medical Center), Eszter Szentirmai(Twitter (United States)), Josh M. Heck(Twitter (United States)), David Leverenz(Twitter (United States)), Kathryn Goggins(Twitter (United States)), Meghan Kapp(Twitter (United States)), Cody H. Penrod(Twitter (United States)), Cecelia Theobald(Twitter (United States)), Irene Valerio-Navarrete(Twitter (United States)), Kevin Flemmons(Twitter (United States)), Michael A. Vella(University of Pennsylvania), Kelly C. Sponsler(Twitter (United States)), Donald Brady(Twitter (United States)), Patricia Kleinholz(Twitter (United States))
Cited by 58
Related Papers
Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)
|Journal for ImmunoTherapy of Cancer|2018|468
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|459
Immunotherapeutic approaches for small-cell lung cancer
|Nature Reviews Clinical Oncology|2020|346
Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC)
|Scientific Reports|2018|258
Molecular Pathways: Clinical Applications and Future Direction of Insulin-like Growth Factor-1 Receptor Pathway Blockade
|Clinical Cancer Research|2015|178